Table IV.
Predictive factors | AUC | 95% CI | Sensitivity, % | Specificity, % | P-value |
---|---|---|---|---|---|
SUVmax(T) | 0.830 | 0.768-0.892 | 87.7 | 63.8 | <0.001 |
SUVmax(N) | 0.777 | 0.634-0.842 | 88.2 | 53.2 | <0.001 |
CEA | 0.632 | 0.546-0.719 | 68.1 | 67.0 | <0.001 |
SUVmax(T)+SUVmax(N) | 0.876 | 0.821-0.930 | 82.4 | 81.3 | <0.001 |
SUVmax(T)+SUVmax(N)+CEA | 0.877 | 0.824-0.931 | 85.3 | 75.1 | <0.001 |
SUVmax(T)+SUVmax(N)+CEA+smoking status | 0.886 | 0.835-0.937 | 82.1 | 80.3 | <0.001 |
SUVmax, maximum standardized uptake value; CEA, carcinoembryonic antigen; CI, confidence interval; AUC, area under the curve, SUVmax(T), SUVmax in primary lesions; SUVmax(N), SUVmax in metastatic lymph nodes.